Ligand Pharmaceuticals | LGND - Capitalización De Mercado





Capitalización De Mercado Cambio Fecha
Agenus USD 128M 21M 2026-03
Amgen USD 195.44B 5.55B 2026-06
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 11.5B 2.72B 2026-06
Baxter International USD 11.01B 2.34B 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Eli Lilly USD 1.13T 260.54B 2026-06
Enanta Pharmaceuticals USD 122M 98M 2024-12
Enviri Corporation USD 1.45B 423M 2025-12
Gilead Sciences USD 156.86B 16.13B 2026-06
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Glaxosmithkline GBP 109.29B 9.36B 2026-03
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 23.11B 12.19B 2026-06
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Karyopharm Therapeutics USD 126M 9M 2026-03
Ligand Pharmaceuticals USD 6.34B 2.35B 2026-06
MacroGenics USD 184M 82M 2026-03
Merck USD 317.37B 20.27B 2026-06
Pacira USD 998M 83M 2026-06
Pfizer USD 138.44B 15.37B 2026-06
Veracyte USD 4.69B 2.12B 2026-06